Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Inherent Targeting
AddedFeb 18, 2024
UpdatedJun 18, 2026
Inherent Targeting

Inherent Targeting

Acquired

Inherent Targeting develops fluorescent agents for nerve-targeting, enhancing surgical outcomes.

HQ
Portland, OR, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Inherent Targeting was founded with the mission to revolutionize surgical procedures through the development of innovative fluorescent contrast agents. These agents are specifically designed to target nerves, thereby enhancing the precision and safety of surgeries. The company envisions a future where surgical outcomes are significantly improved through advanced imaging technologies. Their primary market focus includes medical professionals and healthcare institutions seeking to adopt cutting-edge solutions for better patient care.

Notable affiliated individuals and investors include leading experts in biomedical engineering and venture capital firms specializing in healthcare innovations. Inherent Targeting has achieved significant milestones, including successful clinical trials and partnerships with major medical institutions. The overall impact of their technology is evident in the improved accuracy and reduced risk in surgical procedures, positioning them as a key player in the medical imaging industry.

Inherent Targeting - Similar Companies

Vergent Bioscience logo

Vergent Bioscience

vergentbio.com

On Target Laboratories logo

On Target Laboratories

Curadel Surgical Innovations logo

Curadel Surgical Innovations

OnLume logo

OnLume

onlume.com

Perceptive Navigation logo

Perceptive Navigation

Renerva logo

Renerva

renerva.com

Illuminare Biotechnologies logo

Illuminare Biotechnologies

illuminarebio.com

surgical.ai logo

surgical.ai

surgical.ai

IntraVu logo

IntraVu

intravu.com

MindTrace logo

MindTrace

Inherent Biosciences logo

Inherent Biosciences

inherentbio.com

Neuro42 logo

Neuro42

Niche Biomedical logo

Niche Biomedical

Checkpoint Surgical logo

Checkpoint Surgical

Reveal Pharmaceuticals logo

Reveal Pharmaceuticals

Inherent Targeting - Quick Facts

Who are Inherent Targeting's competitors?

Companies similar to Inherent Targeting include Vergent Bioscience, On Target Laboratories, Curadel Surgical Innovations and OnLume.

When was Inherent Targeting founded?

Inherent Targeting was founded in 2019.

Where is Inherent Targeting's headquarters located?

Inherent Targeting's headquarters is located in Portland, OR, US.

How much has Inherent Targeting raised to-date?

As of Dec 1, 2021, Inherent Targeting has raised a total of $244.3k (USD).

Inherent Targeting - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Contrast Agents
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified